Stemson Therapeutics, founded in 2018, stands at the intersection of Biotechnology and Health and Wellness. With a vision to combat the emotional trauma and social stigma associated with hair loss, the company is committed to offering a groundbreaking solution that does more than just mask the problem. Their slogan, "Regenerate Hair, Rejuvenate Life," encapsulates their mission to enable individuals to reclaim their natural hair, potentially transforming their lives.
Headquartered in the United States, Stemson Therapeutics has garnered significant investor interest, most recently securing a $15.00 million Series A investment on 01 July 2021. Notable investors in this round included DCVC, Genoa Ventures, and AbbVie Ventures. The strong backing from these investors underscores the confidence in Stemson’s innovative approach and the potential impact of their research and development efforts in the sector.